This is not a growth-at-a-reasonable-price story — it’s a balance sheet stress story trading on hope. A Forward P/E of 160.1 combined with a negative operating margin of -4.00% signals investors are paying an extreme premium for earnings that are not materializing, while the Altman Z-Score of 0.3 flashes severe financial distress risk. The company posts just 3.20% ROE and 0.10% ROIC, meaning capital is barely productive, yet leverage sits at 7.80% Debt/Equity with a weak 0.7 current ratio. There is no evidence here of mispricing to the upside; if anything, the market appears dangerously complacent about balance sheet fragility and forward earnings deterioration, especially with EPS expected at -$0.40 next year.